Cited by 63Medicinal Plants and NeuroprotectionAlzheimer's disease research and treatmentsNatural product bioactivities and synthesis

Alzheimer’s Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms

Open access
Abduljawad, Asaad A., Elawad, Mohammed Ahmed, Elkhalifa, Modawy Elnour Modawy, Ahmed, Alshebli, Hamdoon, Alashary Adam Eisa, Salim, Liga Hasan Mohammed, Ashraf, Muhammad, Ayaz, Muhammad +2 more·2022·Molecules

Abstract

Saponins are triterpenoid or steroidal glycosides and are an important group of naturally occurring compounds of plant origin. They exhibit diverse pharmacological potentials including radical scavenging, as well as neuroprotective, anti-diabetic and anti-inflammatory activities, owing to their diverse chemical scaffolds. Saponins consist of an aglycone part (non-sugar) and a glycone part (sugar) and have at least one glycosidic (C–O sugar bond) linkage present between the glycone and aglycone mostly at C-3. On the basis of the aglycone part, saponins are classified into triterpenoid glycosides, steroid glycosides and alkaloid glycosides. Saponins exhibit neuroprotective activities against various disorders of the central nervous system (CNS) including stroke, Alzheimer’s disease (AD), Huntington’s disease (HD) and Parkinson’s disease (PD). They mediate their therapeutic effects by modulation of various pathological targets. This study highlights various neuroprotective mechanisms of saponins including free radical scavenging, modulation of neuroprotective signaling pathways, activation of neurotrophic factors, modulation of neurotransmitters, inhibition of BACE1 enzyme and tau hyper-phosphorylation. The study concludes that saponins have considerable efficacy against various pathological targets of neurological disorders, especially AD, and might be an important source of leads against neurodegenerative disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules27206804

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The blood-brain barrier (BBB) is an important impediment to the development of AD medications because it prevents potential drug candidates from entering the brain parenchyma.

    “An important impediment to the development of AD medications is the blood–brain barrier (BBB), which prevents potential drug candidates from entering the brain parenchyma.”
  • The indicated BBB penetration values are inconsistent with the physicochemical characteristics of monoclonal antibodies (solanezumab, aducanumab, bapineuzumab) or gamma-secretase inhibitors (semagacestat, tarenflurbil).

    “The indicated BBB penetration values are inconsistent with the physicochemical characteristics of monoclonal antibodies (solanezumab, aducanumab, bapineuzumab) or gamma-secretase inhibitors (semagacestat, tarenflurbil) [193,194,195].”
  • Candidates for BBB penetration are characterized by molecular weight less than 450 Daltons, polar surface area less than 90 Å2, and hydrogen bond donor number less than 3.

    “A molecular weight less than 450 Daltons, a polar surface area less than 90 Å2, and a hydrogen bond donor number less than 3 are characteristics of candidates for BBB penetration.”
  • For a medicine to penetrate the BBB, its physicochemical properties-polar surface area, molecular weight, and lipophilicity as assessed by hydrogen bonding ability-are essential.

    “For a medicine to penetrate the blood–brain barrier, its physicochemical properties—such as its polar surface area, molecular weight, and lipophilicity as assessed by hydrogen bonding ability—are essential.”
  • The BBB is impermeable to 98% of small molecules and around 100% of large molecules in relevant quantities.

    “The BBB is impermeable to 98% of small molecules and around 100% of large molecules in relevant quantities.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

4 of the 132 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [85]Hostettmann K. Marston A. Saponins Cambridge University Press Cambridge, UK 2005
  2. [91]Hostettmann K. Marston A. Chemistry and Pharmacology of Natural Products Cambridge University Press Cambridge, UK 1995 Volume 548

Cited by

Sorted by citations

Authors
Abduljawad, A. A., Elawad, M. A., Elkhalifa, M. E. M., Ahmed, A., Hamdoon, A. A. E., Salim, L. H. M., Ashraf, M., Ayaz, M., Hassan, S. S. U., & Bungau, S.
Affiliations
  • Umm al-Qura University (SA)
  • University of Khartoum (SD)
  • University of Malakand (PK)
  • Shanghai Jiao Tong University (CN)
  • University of Oradea (RO)
Corresponding author
  • Abduljawad, Asaad A.
  • Ayaz, Muhammad
  • Hassan, Syed Shams ul
  • Bungau, Simona
Venue
Molecules
Publisher
MDPI AG
Published
2022-10-11
Volume
27
Issue
20
Pages
6804
ISSN
1420-3049 (ISSN-L)
OpenAlex
W4304632685
Cited by
63
References
132
Citations by year
2026: 7 · 2025: 24 · 2024: 14 · 2023: 16 · 2022: 2
FWCI
3.23
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Natural product bioactivities and synthesis
Keywords
saponins, Alzheimer's disease, neurodegenerative diseases, neuroprotection, triterpenoid saponins, steroid glycosides, free radical scavenging, neurotrophic factors, neurotransmitters, BACE1 inhibition, tau hyperphosphorylation, Huntington's disease, Parkinson's disease, dietary phytochemicals
MeSH terms
Alzheimer Disease, Free Radicals, Glycosides, Humans, Nerve Growth Factors, Public Health, Saponins, Steroids, Triterpenes, Aspartic Acid Endopeptidases, Neurotransmitter Agents, Neurodegenerative Diseases, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review